Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 492 results found. Search for [ Drug sales in India ]

Results 1 to 21 of 492
E Kumar Sharma
January 28, 2020
According to analysts, the company posted \"a good set of numbers, especially from the point of margin performance\" for the third quarter. As for the USFDA inspection, the current inspection gains importance given that it is last of the pending warning letters awaiting clearance


BusinessToday.In
January 24, 2020
Share Market Update: YES Bank, Coal India, Britannia, Coal India, Larsen and Toubro and NTPC were among the top gainers today. Power Grid, Bahrti Airtel, Infosys, Cipla and TCS were trading among the top losers.


BusinessToday.In
January 23, 2020
Share Market Update: Sensex ended 271 points higher at 41,386 and Nifty closed 73 points higher at 12,179


BusinessToday.In
January 20, 2020
Share Market Update: BSE Sensex ended 400 points lower at 41,528 and NSE Nifty traded 121 points lower at 12,230 by the closing bell.


PB Jayakumar
New Delhi, January 7, 2020
How the merger of MNC giants Bayer and Monsanto is likely to pan out in India


BusinessToday.In
January 7, 2020
Share Market Update :BSE S&P Sensex closed 206 points higher at 40,883 and NSE Nifty50 ended 62 points higher at 12,055


BusinessToday.In
January 3, 2020
Share Market Update: Domestic indices followed global markets that erased early gains on Friday in wake of sharp spike in crude prices after a US strike eliminated a top Iranian commander.


E Kumar Sharma
New Delhi, December 31, 2019
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive


PB Jayakumar
December 28, 2019
Nutraceuticals, which consist of vitamins and minerals, protein supplements, energy drinks and growth supplements, have clocked higher growth than prescription drugs


PB Jayakumar
New Delhi, December 26, 2019
Sun Pharma's issues with Halol was started in 2015, as the FDA issued a 'warning letter' subsequent to an inspection in September 2014


Reuters
New Delhi, December 22, 2019
Novartis's AveXis unit, which developed Zolgensma will allocate 50 doses of the world's costliest single-dose treatment through June for babies under 2 years old, says Novartis


PB Jayakumar
December 19, 2019
Arjun Deshpande's unique pharmacy chain Generic Aadhar sells generic medicines to the masses at much cheaper rates than the market price


E Kumar Sharma
December 18, 2019
Industry watchers, however, say that it may lead to some pharma players opting more for medicines not falling under the drug price control regime


BusinessToday.In
December 16, 2019
Stocks in the news: YES Bank, Cipla, Magma Fincorp, JM Financial, Shriram Transport among others are the top stocks to watch out for Tuesday's trading session


BusinessToday.In
December 16, 2019
Share Market : Key benchmark indices Sensex and Nifty turned volatile and ended lower on Monday, tracking global equities


Joe C Mathew
New Delhi, December 10, 2019
According to AIDAN, the agreements the company has drawn up with doctors in the guise of consultancy are not only illegitimate and unethical, but also undermine the medical practitioner's autonomy and professional integrity


E Kumar Sharma
New Delhi, December 10, 2019
Diabetes drug price: Companies are talking of a significant price cut. Intas Pharmaceuticals, according to a senior official in the company, will hit the market today with two versions


PB Jayakumar
December 4, 2019
It is estimated that India has about 50 internet pharmacies in the organised sector with total revenues of Rs 2,500-Rs 3,000 crore


Reuters
December 4, 2019
Trader groups have protested for years against e-pharmacies, saying they challenge their businesses and could allow medicines to be abused by being sold without proper verification


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PAGES 1 OF 25  12345